The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of amrubicin for previously treated patients with malignant pleural mesothelioma.
 
Kazumasa Akagi
No Relationships to Disclose
 
Takaya Ikeda
No Relationships to Disclose
 
Katsumi Nakatomi
No Relationships to Disclose
 
Hirokazu Taniguchi
No Relationships to Disclose
 
Midori Shimada
No Relationships to Disclose
 
Hiroshi Gyotoku
No Relationships to Disclose
 
Yosuke Dotsu
No Relationships to Disclose
 
Yasuhiro Umeyama
No Relationships to Disclose
 
Hiromi Tomono
No Relationships to Disclose
 
Takeshi Kitazaki
No Relationships to Disclose
 
Masaaki Fukuda
No Relationships to Disclose
 
Hiroshi Soda
No Relationships to Disclose
 
Hiroaki Senju
No Relationships to Disclose
 
Shinnosuke Takemoto
No Relationships to Disclose
 
Hiroyuki Yamaguchi
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly
Research Funding - Boehringer Ingelheim; Lilly; Novartis
 
Minoru Fukuda
Honoraria - Chugai Pharma; Daiichi Sankyo; Kiowa Kirin; Lilly; Ono Pharmaceutical; Roche
Research Funding - AZD (Inst); Lilly (Inst); MSD (Inst)
 
Hiroshi Mukae
Honoraria - Abbvie; Asahi Kasei; Astellas Pharma; AstraZeneca Japan; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Fujifilm; Kyorin; Mediart Corporation; Merck Sharp & Dohme; Miyarisan Pharmaceutical; MSD Life Science Foundation; Nikkei Radio Broadcasting Corporation; Nippon Boehringer Ingelheim; Novartis; Pfizer; Public Interest Incorporated Foundation; Shionogi; Sumitomo Group; Taiho Pharmaceutical; Taisho Pharmaceutical Holdings
Research Funding - Asahi Kasei (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Fujifilm (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Taisho Pharmaceutical Holdings (Inst); Teijin Pharma (Inst); Torii Pharmaceutical (Inst)